Measuring Surgical Waiting Times in Breast Cancer: Admission to Surgery Versus Biopsy Result to Surgery
Open Access
- 21 November 2025
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 13 (23)
Abstract
Background: Preoperative timelines may lengthen due to tailored evaluation and system constraints. We examined whether two complementary measures of time-to-surgery (TTS)—admission-to-surgery (A-TTS) and biopsy-result-to-surgery (B-TTS)—behave similarly and whether parallel tracking offers service value. Methods: In a single-center retrospective cohort of eligible women undergoing upfront surgery for invasive breast cancer (2010–2021; n = 167), we reported quality indicators for timeliness (target attainment, agreement and discordance, the interval gap, and the surgery-to-adjuvant interval), while analyzing recurrence as the primary endpoint and overall survival as secondary. Discrimination analyses, logistic regression, and Cox models were used; non-proportional hazards were handled with a log–time interaction centered at 24 months. Results: The two time measures were not interchangeable: discordant cases were frequent and pointed to different bottlenecks. A-TTS ≤ 24 days was independently associated with recurrence (OR 3.16; 95% CI 1.13–8.82) and showed a large early hazard for death at 24 months that attenuated over time (HR 22.83; 95% CI 6.44–80.98; interaction HR 0.06; 95% CI 0.02–0.21), whereas B-TTS showed no association. Conclusions: Lymphovascular invasion remained the strongest pathologic correlate of survival. Tracking both intervals, paired with brief, reason-coded reviews of discordant cases, may support scheduling, quality dashboards, and breach governance better than a single TTS metric.Keywords
This publication has 30 references indexed in Scilit:
- Quantifying the impact of treatment delays on breast cancer survival outcomes: a comprehensive meta-analysisGeroScience, 2025
- Fragmentation of care in breast cancer: greater than the sum of its partsBreast Cancer Research and Treatment, 2024
- Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational studyBreast Cancer Research and Treatment, 2024
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- Reexamining Time From Breast Cancer Diagnosis to Primary Breast SurgeryJAMA Surgery, 2023
- Time to Treatment Initiation for Six Cancer Types: An Analysis of Data from a Nationwide Registry in JapanWorld Journal of Surgery, 2023
- Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?Clinical Breast Cancer, 2022
- Oncoplastic breast surgery: A guide to good practiceEuropean Journal of Surgical Oncology, 2021
- Time to Surgery and Breast Cancer Survival in the United StatesJAMA Oncology, 2016
- Effect of longer health service provider delays on stage at diagnosis and mortality in symptomatic breast cancerThe Breast, 2015